510(k) Report

510(k) · Cleared

Cleared

Atalante X

K250904510(k) TraditionalCleared Oct 24, 2025212-day reviewClass II21 CFR 890.3480

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Wandercraft SAS · PHL Powered Exoskeleton

Cleared on Oct 24, 2025 as substantially equivalent to K232077 (Wandercraft SAS, 2023) after a 212-day review. Its family tree reaches back 7 generations to 2014. 1 later device descends from it.

Decided
Oct 24, 2025
Review
212 days
Class
Class II
Product code
PHL
Recalls
None
Predicates
1

Its longest line of descent runs back 7 generations to DEN130034 (2014). 8 ancestors in all. 1 later device descends from it, 1 citing it directly.

  1. Root · 7 generations backDEN130034 RewalkArgo Medical Technologies, Inc. · 2014
  2. 6 generations backK143690 Ekso™ (version 1.1) and Ekso GT™ (version 1.2)Ekso Bionics, Inc. · 2016
  3. 5 generations backK161443 Ekso™ (version 1.1) and Ekso GT™ (version 1.2)Ekso Bionics, Inc. · 2016
  4. 4 generations backK171334 IndegoParker Hannifin Corporation · 2017
  5. 3 generations backK173530 Indego (R)Parker-Hannifin Corporation · 2018
  6. 2 generations backK221859 AtalanteWandercraft SAS · 2022 · Recalled
  7. 1 generation backK232077 Atalante XWandercraft SAS · 2023
  8. This deviceK250904 Atalante XWandercraft SAS · 2025
  9. Descendant · cites it directly · 0 of its ownK260381 EveWandercraft SAS · 2026

Most influential descendants

Showing 1 of 1 · See all
  • K260381EveWandercraft SAS · 2026 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−7DEN130034RewalkArgo Medical Technologies, Inc.2014—
−6K143690Ekso™ (version 1.1) and Ekso GT™ (version 1.2)Ekso Bionics, Inc.2016—
−5K161443Ekso™ (version 1.1) and Ekso GT™ (version 1.2)Ekso Bionics, Inc.2016—
−4K171334IndegoParker Hannifin Corporation2017—
−3K173530Indego (R)Parker-Hannifin Corporation2018—
−2K221859AtalanteWandercraft SAS20221
−1K232077Atalante XWandercraft SAS2023—
0 (this device)K250904Atalante XWandercraft SAS2025—
+1K260381EveWandercraft SAS2026—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
201610

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202610
FIG. 1 — Lineage of K250904, 2014–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in PHL? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new PHL device

  1. #1 K260381 Evescore 13.9 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K232077Atalante X
Summary page 6
…Predicate Device Reference Device Device name Atalante X EksoNR 510(K) number K232077 K220988 Regulation Number 21 CFR 890.3480 21 CFR 890.3480…
Wandercraft SAS2023—
†K220988EksoNREkso Bionics, Inc.2022—

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K260381EveWandercraft SAS20260

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 11 years and passes through 5 companies; a new generation was cleared every 1.1 years on median.
  • 1 of the 8 ancestors has a recall of any class.
  • Of its descendants, K260381 (Wandercraft SAS, 2026) has gone furthest, with 0 descendants of its own.

How does its category compare?

All PHL devices

PHL Powered Exoskeleton: FDA decisions, review times, recalls and adverse event reports over 20 years. 2025, this device’s year, is highlighted.

FDA decisions per year · PHL

2in 2025

2014: 12016: 42017: 22018: 22019: 22020: 42021: 12022: 32023: 22024: 12025: 22026 (partial year): 2
2007high 4 (2016) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · PHL

177in 2022

2016: 145 days median2020: 110 days median2022: 177 days median
2007high 177 (2022) · low 110 (2020)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · PHL

1in 2017

2017: 1
2007high 1 (2017) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · PHL

6in 2025

2015: 12016: 42017: 82018: 212020: 32021: 22022: 22023: 12024: 62025: 6
2007high 21 (2018) · low 0 (2007)2025

MAUDE reports naming product code PHL, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20141—00
20150—01
2016414504
20172—18
20182—021
20192—00
2020411003
20211—02
2022317702
20232—01
20241—06
20252—06
20262—0—

What is it indicated for?

Atalante X is intended to perform ambulatory functions and mobility exercises, hands-free, in rehabilitation institutions under the supervision of a trained operator for the following populations:

* Individuals with hemiplegia due to cerebrovascular accident (CVA)

* Individuals with spinal cord injuries at levels C4 to L5 (SCI)

* Individuals with multiple sclerosis (MS)

The operator must complete a training program prior to use of the device.

Atalante X is intended to be used on adolescents of 18 years and older, and adults able to tolerate a stand-up position.

The device is not intended for sports or stair climbing.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K250904: Atalante X.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K250904

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026